Skip to content

Author

Mohanraj Gopikrishnan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Computational Elucidation of Potent Ligands Targeting Recalcitrant ALK G1202R‐Associated Double Mutations Underlying Lorlatinib Resistance

Targeting ALK has become a viable therapeutic strategy in non‐small cell lung cancer (NSCLC) following the discovery of the EML4‐ALK fusion. Several inhibitors were developed which improved the patient's outcomes; however, the emergence of drug resistance limits the treatment and poses significant challenges. The s...

P. Bharath, Mohanraj Gopikrishnan, Magesh Ramasamy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.